Neuromelanin(NM)-sensitive MRI (NM-MRI) is a promising technique to study pathological changes in NM-containing structures, such as the substantia nigra pars compacta (SNc). This midbrain structure modulates the corticostriatal pathway through the striatum, which is known to degenerate in Huntington’s Disease (HD). Our study used NM-MRI for the first time to study HD, with a semi-automatic segmentation method to evaluate the SNc, compatible with dopaminergic neuronal loss in the SNc of HD patients. SNc NM correlated with the volumes of the caudate, putamen and globus pallidus, suggesting that SNc neuronal loss and basal ganglia atrophy may not be independent processes.
This abstract and the presentation materials are available to members only; a login is required.